Shakhatreh Lubna, Sinclair Ben, McLean Catriona, Lui Elaine, Morokoff Andrew P, King James A, Chen Zhibin, Perucca Piero, O'Brien Terence J, Kwan Patrick
Department of Neuroscience, The Central Clinical School, Monash University, Melbourne, Australia.
Department of Neurology, The Royal Melbourne Hospital, Melbourne, Australia.
Epilepsia. 2024 Jun;65(6):1709-1719. doi: 10.1111/epi.17968. Epub 2024 Mar 28.
Amygdala enlargement is detected on magnetic resonance imaging (MRI) in some patients with drug-resistant temporal lobe epilepsy (TLE), but its clinical significance remains uncertain We aimed to assess if the presence of amygdala enlargement (1) predicted seizure outcome following anterior temporal lobectomy with amygdalohippocampectomy (ATL-AH) and (2) was associated with specific histopathological changes.
This was a case-control study. We included patients with drug-resistant TLE who underwent ATL-AH with and without amygdala enlargement detected on pre-operative MRI. Amygdala volumetry was done using FreeSurfer for patients who had high-resolution T1-weighted images. Mann-Whitney U test was used to compare pre-operative clinical characteristics between the two groups. The amygdala volume on the epileptogenic side was compared to the amygdala volume on the contralateral side among cases and controls. Then, we used a two-sample, independent t test to compare the means of amygdala volume differences between cases and controls. The chi-square test was used to assess the correlation of amygdala enlargement with (1) post-surgical seizure outcomes and (2) histopathological changes.
Nineteen patients with and 19 patients without amygdala enlargement were studied. Their median age at surgery was 38 years for cases and 39 years for controls, and 52.6% were male. There were no statistically significant differences between the two groups in their pre-operative clinical characteristics. There were significant differences in the means of volume difference between cases and controls (Diff = 457.2 mm, 95% confidence interval [CI] 289.6-624.8; p < .001) and in the means of percentage difference (p < .001). However, there was no significant association between amygdala enlargement and surgical outcome (p = .72) or histopathological changes (p = .63).
The presence of amygdala enlargement on the pre-operative brain MRI in patients with TLE does not affect the surgical outcome following ATL-AH, and it does not necessarily suggest abnormal histopathology. These findings suggest that amygdala enlargement might reflect a secondary reactive process to seizures in the epileptogenic temporal lobe.
在一些耐药性颞叶癫痫(TLE)患者的磁共振成像(MRI)上检测到杏仁核增大,但其临床意义仍不明确。我们旨在评估杏仁核增大是否(1)预测了前颞叶切除术联合杏仁核海马切除术(ATL-AH)后的癫痫发作结果,以及(2)与特定的组织病理学变化相关。
这是一项病例对照研究。我们纳入了接受ATL-AH的耐药性TLE患者,这些患者术前MRI检测到有或没有杏仁核增大。对于有高分辨率T1加权图像的患者,使用FreeSurfer进行杏仁核体积测量。采用曼-惠特尼U检验比较两组术前的临床特征。比较病例组和对照组中致痫侧杏仁核体积与对侧杏仁核体积。然后,我们使用两样本独立t检验比较病例组和对照组之间杏仁核体积差异的均值。采用卡方检验评估杏仁核增大与(1)术后癫痫发作结果和(2)组织病理学变化的相关性。
研究了19例有杏仁核增大的患者和19例无杏仁核增大的患者。病例组手术时的中位年龄为38岁,对照组为39岁;52.6%为男性。两组术前临床特征无统计学显著差异。病例组和对照组在体积差异均值(Diff = 457.2 mm,95%置信区间[CI] 289.6 - 624.8;p <.001)和百分比差异均值(p <.ooo1)上存在显著差异。然而,杏仁核增大与手术结果(p = 0.72)或组织病理学变化(p = 0.63)之间无显著关联。
TLE患者术前脑MRI上杏仁核增大的存在不影响ATL-AH后的手术结果,也不一定提示组织病理学异常。这些发现表明,杏仁核增大可能反映了致痫颞叶中癫痫发作的继发反应过程。